Goodwin congratulated Superluminal Medicines Inc. and its investors on a milestone.
Public source
Publisher name
Public post
Congratulations to Superluminal Medicines Inc. and its investors! A very exciting milestone- a pleasure to work with all involved.
Company
Goodwin
- Industry
- Law Practice
- Location
- Boston, US
- Company size
- 1,001–5,000 employees
About Goodwin
At Goodwin, we live your business. We are a firm of insiders relentlessly focused on understanding the pulse within six industries: healthcare, investment funds, life sciences, private equity, real estate, and technology. This means that we deliver unprecedented client value through a unique combination of industry knowledge, legal excellence, and business advisory expertise – all powered by our high-performance culture. For more on life at Goodwin, follow us on Instagram: @Join_Goodwin Content may include attorney advertising.
See moreLatest activity
Latest activity from Goodwin
27 signals
Presence & Recognition
Goodwin, Ledgy, PwC, and Jamieson Corporate Finance will bring together perspectives from across the private equity market for a breakfast panel on Management Incentive Plans in the Age of AI on 22 September in Central London.
Research & Knowledge
Goodwin highlighted ideas articulated in the 2017 SAFT White Paper that are finally formalized in Regulation Crypto.
Presence & Recognition
Goodwin recognized the National Multifamily Housing Council's Real Estate Technology & Transformation Center's OPTECH honorees for physical AI in the multifamily space, including forREAL, a team represented by Nikolaos Vlavianos PhD and his team.
Discover more
Similar signals
Similar public activity from other companies.
Capital & Finance
LifeSci Consulting
LifeSci Consulting congratulated Superluminal Medicines Inc. on its Series B funding announcement.
Capital & Finance
Mintz
Mintz supported the $21M Series A financing for client Retro.
Capital & Finance
bioSeedin
bioSeedin reported that Superluminal Medicines Inc. raised an oversubscribed Series B led by BVF Partners for $60 million.
Capital & Finance
Davis Polk & Wardwell LLP
Davis Polk & Wardwell LLP partnered with Morgan Health on the lead investment in Thyme Companies’ Series E financing round of over $125 million.
Capital & Finance
Raven Healthcare Incubator (RA Capital)